Literature DB >> 24313269

Alternative techniques for left ventricular pacing in cardiac resynchronization therapy.

Attila Mihalcz1, Imre Kassai, Laszlo Geller, Tamas Szili-Török.   

Abstract

Cardiac resynchronization therapy (CRT) is an important treatment modality for a well-defined subgroup of heart failure patients. Coronary sinus (CS) lead placement is the first-line clinical approach but the insertion is unsuccessful in about 5-10% of the patients. In recent years, the number of CRT recipients and the considerable need for left ventricular (LV) lead revisions increased enormously. Numerous techniques and technologies have been specifically developed to provide alternatives for the CS LV pacing. Currently, the surgical access is most frequently used as a second choice by either minithoracotomy or especially the video-assisted thoracoscopy. The transseptal or transapical endocardial LV lead implantations are being developed but there are no longer follow-up data in larger patient cohorts. These new techniques should be reserved for patients failing conventional or surgical CRT implants. In the future, randomized studies are needed to asses the potential benefits of some alternative LV pacing techniques and other new technologies for LV lead placement are expected. ©2013, The Authors. Journal compilation ©2013 Wiley Periodicals, Inc.

Entities:  

Keywords:  cardiac resynchronization; endocardial; epicardial; pacing

Mesh:

Year:  2013        PMID: 24313269     DOI: 10.1111/pace.12320

Source DB:  PubMed          Journal:  Pacing Clin Electrophysiol        ISSN: 0147-8389            Impact factor:   1.976


  9 in total

1.  Leadless left ventricular endocardial pacing: a real alternative or a luxury for a few?

Authors:  Elia De Maria; Matteo Ziacchi; Igor Diemberger; Mauro Biffi
Journal:  Cardiovasc Diagn Ther       Date:  2018-08

Review 2.  Leadless pacing.

Authors:  J Sperzel; C Hamm; A Hain
Journal:  Herz       Date:  2018-11       Impact factor: 1.443

3.  A Novel Approach for Repetitive Dislocation of Transvenous Left Ventricular Leads During Cardiac Resynchronization Therapy Implantation by the Loop Technique.

Authors:  Hao-Yu Wu; Shang-Jian Li; Zheng Yang; Hai-Chao Chen; Peng-Hua You; Gong Cheng
Journal:  Front Cardiovasc Med       Date:  2022-06-21

Review 4.  Leadless Cardiac Pacemakers: Pacing Paradigm Change.

Authors:  Petr Neuzil; Vivek Y Reddy
Journal:  Curr Cardiol Rep       Date:  2015-08       Impact factor: 2.931

Review 5.  Comparative efficacy of image-guided techniques in cardiac resynchronization therapy: a meta-analysis.

Authors:  Xiao Hu; Hai Xu; Shameer Raaj Avishkar Hassea; Zhiyong Qian; Yao Wang; Xinwei Zhang; Xiaofeng Hou; Jiangang Zou
Journal:  BMC Cardiovasc Disord       Date:  2021-05-24       Impact factor: 2.298

6.  Trans-Fontan baffle placement of an endocardial systemic ventricular pacing lead.

Authors:  Elizabeth DeWitt; Ryan Callahan; Elizabeth Blume; Audrey Marshall; Douglas Mah
Journal:  HeartRhythm Case Rep       Date:  2016-12-21

7.  Transvenous versus open chest lead placement for resynchronization therapy in patients with heart failure: comparison of ventricular electromechanical synchronicity.

Authors:  Hai-Bo Zhang; Xu Meng; Jie Han; Yan Li; Ye Zhang; Teng-Yong Jiang; Ying-Xin Zhao; Yu-Jie Zhou
Journal:  J Geriatr Cardiol       Date:  2017-04       Impact factor: 3.327

8.  Overview of Current Strategies Aiming at Improving Response to Cardiac Resynchronization Therapy.

Authors:  Yakup Yunus Yamantürk; Başar Candemir; Emir Baskovski; Kerim Esenboğa
Journal:  Anatol J Cardiol       Date:  2022-05       Impact factor: 1.475

9.  Epicardial left ventricular lead implantation in cardiac resynchronization therapy patients via a video-assisted thoracoscopic technique: Long-term outcome.

Authors:  Massimiliano Marini; Stefano Branzoli; Paolo Moggio; Marta Martin; Giuseppina Belotti; Giulio Molon; Fabrizio Guarracini; Alessio Coser; Silvia Quintarelli; Carlo Pederzolli; Angelo Graffigna; Daniele Penzo; Sergio Valsecchi; Maria Caterina Bottoli; Patrizia Pepi; Roberto Bonmassari; Andrea Droghetti
Journal:  Clin Cardiol       Date:  2019-12-14       Impact factor: 2.882

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.